Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
Younes, Anas, Burke, John M., Cheson, Bruce D., Diefenbach, Catherine S., Ferrari, Silvia, Hahn, Uwe H., Hawkes, Eliza A., Khan, Cyrus, Lossos, Izidore S., Musuraca, Gerardo, Tani, Monica, Vitolo, Umberto, Yuen, Sam, Raval, Aparna, Shivhare, Mahesh, Nielsen, Tina G., Sellam, Gila, Sharman, Jeff P.
Published in Blood advances (25.04.2023)
Published in Blood advances (25.04.2023)
Get full text
Journal Article
Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early Stage Classic Hodgkin Lymphoma: Interim Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part C)
Lee, Hun Ju, Abramson, Jeremy S., Bartlett, Nancy L., Burke, John M., Lynch, Ryan C., Eva, Domingo Domenech, Hess, Brian T., Schuster, Steven R., Linhares, Yuliya, Ramchandren, Rod, Gandhi, Mitul, Mowat, Rex, Shah, Harsh, Rossi, Giuseppe, Hahn, Uwe H, Prince, Henry Miles, Ho, Linda, Guo, Wenchuan, Yasenchak, Christopher A., Straus, David J.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)
Wei, Andrew H, Kennedy, Glen A, Morris, Kirk L, Grigg, Andrew, He, Simon, Schwarer, Anthony, Ting, Stephen B, Enjeti, Anoop Kumar, Yuen, Sam, D'Rozario, James, Latimer, Maya, Marlton, Paula, Bilmon, Ian, Taper, John, Cull, Gavin, Tiley, Campbell, Verner, Emma, Hahn, Uwe H, Hiwase, Devendra K, Iland, Harry, Murphy, Nichloas, Ravanathan, Sundra, Nguyen, Uyen, Ong, Doen Ming, Loo, Sun, Tiong, Ing-Soo, Wall, Meaghan, Anstee, Natasha S, Levis, Mark, Murray, Michael, Rawling, Tristan, Leadbetter, Joanna, Bajel, Ashish, Roberts, Andrew W
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study
Younes, Anas, Burke, John M, Cheson, Bruce D., Diefenbach, Catherine, Ferrari, Silvia, Hahn, Uwe H, Hawkes, Eliza A, Khan, Cyrus, Lossos, Izidore S., Musuraca, Gerardo, Tani, Monica, Vitolo, Umberto, Yuen, Sam Lung Sang, Raval, Aparna, Shivhare, Mahesh R., Nielsen, Tina G, Sellam, Gila, Sharman, Jeff P.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Awan, Farrukh T., Hillmen, Peter, Hellmann, Andrzej, Robak, Tadeusz, Hughes, Steven G., Trone, Denise, Shannon, Megan, Flinn, Ian W., Byrd, John C.
Published in British journal of haematology (01.11.2014)
Published in British journal of haematology (01.11.2014)
Get full text
Journal Article
Increased Idarubicin Dosage during Consolidation Therapy for Adult Acute Myeloid Leukemia Improves Leukemia-Free Survival
Kenneth, Bradstock, Link, Emma, Di Iulio, Juliana, Szer, Jeff, Marlton, Paula, Wei, Andrew, Enno, Arno, Schwarer, Anthony P, Lewis, Ian D., D'Rozario, James, Coyle, Luke, Cull, Gavin, Campbell, Philip, Leahy, Michael Francis, Hahn, Uwe H, Cannell, Paul, Tiley, Campbell, Lowenthal, Raymond M., Moore, John, Cartwright, Kimberly, Cunningham, Ilona, Taper, John, Grigg, Andrew, Roberts, Andrew W., Benson, Warwick John, Hertzberg, Mark S, Deveridge, Sandra F., Rowlings, Philip Arthur, Mills, Anthony K., Gill, Devinder S, Bardy, Peter G, Campbell, Lynda, Seymour, John F.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article